Evidencia científica de la relación entre depresión y cáncer de mama: revisión sistemática
##plugins.themes.themeEleven.article.main##
Keywords
Depresión, Cáncer de Mama, Psicooncología
Resumen
El cáncer de mama es la neoplasia maligna más frecuente en mujeres en todo en el mundo. Su diagnóstico y tratamiento puede estar acompañado de síntomas depresivos. La frecuencia de depresión en mujeres con cáncer de mama puede ser tan variada que va desde < 10% a > 70%, dependiendo del instrumento de evaluación, el tipo de población estudiada y el área geográfica. Se ha descrito que la depresión se asocia a factores genético-ambientales; desequilibrio entre los sistemas nervioso central, endócrino e inmunitario; edad de la paciente; presencia de metastasis; quimioterapia, y rehabilitación física. Su tratamiento está basado en diversos tipos de abordajes, como hipnosis, meditación, musicoterapia y manejo del estrés. En México se ha estudiado poco esta relación. El objetivo de este trabajo es realizar una revisión crítica sobre la evidencia científica de la relación entre depresión y cáncer de mama.
Referencias
1. Sirera R, Sánchez PT, Camps C. Inmunología, estrés, depresión y cáncer. Psicooncología. 2006;3(1):35-48. Disponible en:https://revistas.ucm.es/index.php/PSIC/article/view/PSIC0606130035A
2. Garcia JA, Lourenço MT, Mari JJ. The neurobiological basis of psycho-oncology. Braz J Psychiatry. 2016;38(3):181-2. https://doi.org/10.1590/1516-4446-2016-3803
3. PousaRodríguez V, MiguelezAmboage A, HernándezBlázquez M, GonzálezTorres MA, Gaviria M. Depresión y cáncer:una revisión a la práctica clínica. Rev Colombiana Cancerología. 2015;19(3):166-72. https://doi:10.1016/j.rccan.2015.04.005
4. Hartung TJ, Brahler E, Faller H, Harter M, Hinz A, Johansen C, et al. The risk of being depressed is significantly higher in cancer patients than in the general population:Prevalence and severity of depressive symptoms across major cancer types. Eur J Cancer. 2017;72:46-53. https://doi:10.1016/j.ejca.2016.11.017
5. Caruso R, Nanni MG, Riba MB, Sabato S, Grassi L. Depressive Spectrum Disorders in Cancer:Diagnostic Issues and Intervention. A Critical Review. Current Psychiatry Rep. 2017;19(6):33. https://doi:10.1007/s11920-017-0785-7
6. Richard A, Harbeck N, Wuerstlein R, Wilhelm FH. Recover your smile:Effects of a beauty care intervention on depressive symptoms, quality of life, and self?esteem in patients with early breast cancer. Psycho- Oncology. 2019;28:401-7. https://doi.org/10.1002/pon.4957
7. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. https://doi.org/10.3322/caac.21492
8. Kim Y, Carver CS, Hallmayer JF, Zeitzer JM, Palesh O, Neri E, et al. Serotonin transporter polymorphism, depressive symptoms, and emotional impulsivity among advanced breast cancer patients. Support Care Cancer. 2018;26(4):1181-8. https://doi.org/10.1007/s00520-017-3940-0
9. Stinesen Kollberg K, Wiley JF, Ross KM, Jorge-Miller A, Hammen C, Weihs KL, et al. Chronic Stress in Vocational and Intimate Partner Domains as Predictors of Depressive Symptoms After Breast Cancer Diagnosis. Annals Behavioral Medicine. 2019;53(4):33344. https://doi.org/10.1093/abm/kay045
10. Bouchard LC, Fisher HM, Carver CS, Kim Y, Antoni MH. Social comparisons predict health-related quality of life and depressive symptoms across the first year of breast cancer treatment. Psycho? Oncology. 2019;28:3⇵. https://doi.org/10.1002/pon.4954
11. Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings:a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12:16074. https://doi:10.1016/S1470-2045(11)70002-X
12. Fann JR, Thomas RA, Katon WJ, Cowley D, Pepping M, Mcgregor BA, et al. Major depression after breast cancer:a review of epidemiology and treatment. Gen Hosp Psychia. 2008;30(2);11226. https://doi:10.1016/j.genhosppsych.2007.10.008
13. Zhu L, Ranchor AV, Helgeson VS, van der Lee M, Garssen B, Stewart RE, et al. Benefit finding trajectories in cancer patients receiving psychological care:Predictors and relations to depressive and anxiety symptoms. Br J Health Psychol. 2018;23(2):23852. https://doi.org/10.1111/bjhp.12283
14. Rowland JH. Anxiety and the blues after breast cancer:how common are they?CNS Spectr. 1999;4(10):40-54. https://doi:10.1017/s1092852900012359
15. Boyle CC, Stanton AL, Ganz PA, Crespi CM, Bower JE. Improvements in emotion regulation following mindfulness meditation:Effects on depressive symptoms and perceived stress in younger breast cancer survivors. J Consult Clinical Psychol. 2017;85(4):397-402. https://doi:10.1037/ccp0000186
16. Fervaha G, Izard JP, Tripp DA, Rajan S, Leong DP, Siemens DR. Depression and prostate cancer:A focused review for the clinician. Urol Oncol. 2019;37(4):2828. https://doi:10.1016/j.urolonc.2018.12.020
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 5th Edition. Arlington:American Psychiatric Association;2013.
18. Walker J, Hansen CH, Martin P, Symeonides S, Ramessur R, Murray G, et al. Prevalence, associations, and adequacy of treatment of major depression in patients with cancer:a cross-sectional analysis of routinely collected clinical data. Lancet Psychiatry. 2014;1(5):343-50. https://doi:10.1016/S2215-0366(14)70313-X
19. Guinot JL. La depresión en el paciente oncológico en la fase final de la vida. Cuadernos Monográficos de PsicoBioquímica. 2013;2:5-13. Disponible en http://www.psicobioquimica.org/cancer_depresion_1_01.html
20. Watts S, Prescott P, Mason J, McLeod N, Lewith G. Depression and anxiety in ovarian cancer:a systematic review and meta-analysis of prevalence rates. BMJ Open. 2015;5(11):e007618. https://doi:10.1136/bmjopen-2015-007618
21. Spiegel D, Riba MB. Managing anxiety and depression during treatment. Breast J. 2015;21(1):97-103. https://doi:10.1111/tbj.12355
22. Danhauer SC, Addington EL, Sohl SJ, Chaoul A, Cohen L. Review of yoga therapy during cancer treatment. Support Care Cancer. 2017;25(4):1357-72. https://doi:10.1007/s00520-016-3556-9
23. García-Fabela RO. Prevalencia de depresión en una población de pacientes con cáncer. Gaceta Mex Oncología. 2010;9(3):89-93. Disponible en https://biblat.unam.mx/hevila/Gacetamexicanadeoncologia/2010/vol9/no3/2.pdf
24. Maass SW, Roorda C, Berendsen AJ, Verhaak PF, de Bock GH. The prevalence of long-term symptoms of depression and anxiety after breast cancer treatment:A systematic review. Maturitas. 2015;82(1):100-8. https://doi:10.1016/j.maturitas.2015.04.010
25. Cramer H, Lauche R, Paul A, Langhorst J, Kümmel S, Dobos GJ. Hypnosis in breast cancer care:a systematic review of randomized controlled trials. Integr Cancer Ther. 2015;14(1):5-15. https://doi:10.1177/1534735414550035
26. Eason AD, Parris BA. Clinical applications of self-hypnosis:A systematic review and meta-analysis of randomized controlled trials. Psychology Consciousness:Theory, Research, and Practice. 2019;6(3):262-78. https://psycnet.apa.org/doi/10.1037/cns0000173
27. Edwards L. The Other Side of the Valley:Healing Through Altered States of Consciousness. Alresford, Hampshire, UK:O-Books;2019.
28. Wagland R, Richardson A, Armes J, Hankins M, Lennan E, Griffiths P. Treatment-related problems experiences by cancer patients undergoing chemotherapy:a scoping review. Eur J Cancer Care. 2015;24(5):60517. https://doi:10.1111/ecc.12246
29. Vargay A, KalóZS, Zsigmond O, Józsa E, ThurzóT, Kóber G, et al. Analysis of subjective experiences of breast cancer patients receiving hypnosis, music, or special attention, during chemotherapy treatment:A content analysis. Developments Health Sciences. 2018;1(3):70-7. https://doi:10.1556/2066.2.2018.19
30. Montgomery GH, David D, Kangas M, Green S, Sucala M, Bovbjerg DH, et al. Randomized controlled trial of a cognitive-behavioral therapy plus hypnosis intervention to control fatigue in patients undergoing radiotherapy for breast cancer. J Clin Oncol. 2014;32(6):55763. https://doi:10.1200/JCO.2013.49.3437
31. Segal ZV, Williams M, Teasdale J. Mindfulness-based cognitive therapy for depression. Second Edition. Guilford Publications;2018.
32. Reich RR, Lengacher CA, Alinat CB, Kip KE, Paterson C, Ramesar S, et al. Mindfulness-based stress reduction in post-treatment breast cancer patients:immediate and sustained effects across multiple symptom clusters. J Pain Symptom Manage. 2017;53(1):↓. https://doi:10.1016/j.jpainsymman.2016.08.005
33. Bower JE, Crosswell AD, Stanton AL, Crespi CM, Winston D, Arevalo J, et al. Mindfulness meditation for younger breast cancer survivors:a randomized controlled trial. Cancer. 2015;121(8):123140. https://doi:10.1002/cncr.29194
34. Kim YH, Kim HJ, Ahn SD, Seo YJ, Kim SH. Effects of meditation on anxiety, depression, fatigue, and quality of life of women undergoing radiation therapy for breast cancer. Complement Therapies Med. 2013;21(4):3797. https://doi:10.1016/j.ctim.2013.06.005
35. Tang Y, Fu F, Gao H, Shen L, Chi I, Bai Z. Art therapy for anxiety, depression, and fatigue in females with breast cancer:A systematic review. J Psychosoc Oncol. 2018;37(1):7995. https://doi.org/10.1080/07347332.2018.1506855
36. Lengacher CA, Reich RR, Paterson CL, Ramesar S, Park JY, Alinat C, et al. Examination of broad symptom improvement resulting from mindfulness-based stress reduction in breast cancer survivors:a randomized controlled trial. J Clin Oncol. 2016;34(24):282734. https://doi:10.1200/JCO.2015.65.7874
37. Cobeanu O, David D. Alleviation of Side Effects and Distress in Breast Cancer Patients by Cognitive-Behavioral Interventions:A Systematic Review and Meta-analysis. J Clinical Psych Med Settings. 2018;25(4):33555.https://doi:10.1007/s10880-017-9526-7
38. CastrezanaCampos MR. Geografía del cáncer de mama en México. Investigaciones Geográficas.2017;93. http://dx.doi.org/10.14350/rig.56879
39. Leal YA, Reynoso-Noverón N, Aguilar-Castillejos LF, Meneses-García A, Mohar A, Piñeros M. Implementation of the population-based cancer registry in the city of Merida, Mexico:process and early results. Salud Publica Mex. 2020;62:96-104. https://doi.org/10.21149/10501
40. Ornelas-Mejorada RE, Tufiño-Tufiño MA, Sánchez-Sosa JJ. Ansiedad y Depresión en Mujeres con Cáncer de Mama en Radioterapia:Prevalencia y Factores Asociados. Acta Investigación Psicológica. 2011;1(3):40114. Disponible en http://www.scielo.org.mx/pdf/aip/v1n3/v1n3a3.pdf
41. Pérez-Fortis A, Schroevers MJ, Fleer J, Alanís-López P, Veloz-Martínez MG, Ornelas-Mejorada RE, et al. Psychological burden at the time of diagnosis among Mexican breast cancer patients. Psycho-Oncology 2017;26(1):133-6. http://doi:10.1002/pon.4098
42. Sánchez-Huerta MS, Figueroa-López CG, Cacho-Díaz B, Robles-García R. Relación entre síntomas autonómicos con niveles de ansiedad y depresión en mujeres con cáncer de mama. En-Claves Pensamiento. 2016;10(19):146-62.
43. Morales-Chávez M, Robles-García R, Jiménez-Pérez M, Morales- Romero J. Las mujeres mexicanas con cáncer de mama presentan una alta prevalencia de depresión y ansiedad. Salud Publica Mex. 2007;49(4):2478. http://doi:10.1590/s0036-36342007000400003
44. Almanza-Muñoz JJ, RosarioJuárez I, SilvaOrtiz J, HuertaSánchez R. Distrés psicosocial y trastornos mentales en una muestra de pacientes mexicanos con cáncer. Rev Sanid Milit Mex. 2009;63(4):14855.
45. Aguilar-Cordero MJ, Mur-Villar N, Neri-Sanchez M, Pimentel-Ramírez ML, García-Rillo A, Gómez-Valverde E. Breast cancer and body image as a prognostic factor of depression:a case study in Mexico City. Nutr Hosp. 2014;31(1):371-9. http//doi:10.3305/nh.2015.31.1.7863
46. Téllez A, Rodríguez-Padilla C, Martínez-Rodríguez JL, Juárez-García DM, Sánchez-Armas O, Sánchez T, et al. Psychological Effects of Group Hypnotherapy on Breast Cancer Patients During Chemotherapy. Am J Clin Hypn. 2017;60(1):68-84. http//doi:10.1080/00029157.2016.1210497
47. Gerson-Cwilich R, Serrano-Olvera A, Villalobos-Prieto A. Complementary and alternative medicine (CAM) in Mexican patients with cancer. Clin Transl Oncol. 2006;8(3):2007. http//doi 10.1007/s12094-006-0011-2
2. Garcia JA, Lourenço MT, Mari JJ. The neurobiological basis of psycho-oncology. Braz J Psychiatry. 2016;38(3):181-2. https://doi.org/10.1590/1516-4446-2016-3803
3. PousaRodríguez V, MiguelezAmboage A, HernándezBlázquez M, GonzálezTorres MA, Gaviria M. Depresión y cáncer:una revisión a la práctica clínica. Rev Colombiana Cancerología. 2015;19(3):166-72. https://doi:10.1016/j.rccan.2015.04.005
4. Hartung TJ, Brahler E, Faller H, Harter M, Hinz A, Johansen C, et al. The risk of being depressed is significantly higher in cancer patients than in the general population:Prevalence and severity of depressive symptoms across major cancer types. Eur J Cancer. 2017;72:46-53. https://doi:10.1016/j.ejca.2016.11.017
5. Caruso R, Nanni MG, Riba MB, Sabato S, Grassi L. Depressive Spectrum Disorders in Cancer:Diagnostic Issues and Intervention. A Critical Review. Current Psychiatry Rep. 2017;19(6):33. https://doi:10.1007/s11920-017-0785-7
6. Richard A, Harbeck N, Wuerstlein R, Wilhelm FH. Recover your smile:Effects of a beauty care intervention on depressive symptoms, quality of life, and self?esteem in patients with early breast cancer. Psycho- Oncology. 2019;28:401-7. https://doi.org/10.1002/pon.4957
7. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. https://doi.org/10.3322/caac.21492
8. Kim Y, Carver CS, Hallmayer JF, Zeitzer JM, Palesh O, Neri E, et al. Serotonin transporter polymorphism, depressive symptoms, and emotional impulsivity among advanced breast cancer patients. Support Care Cancer. 2018;26(4):1181-8. https://doi.org/10.1007/s00520-017-3940-0
9. Stinesen Kollberg K, Wiley JF, Ross KM, Jorge-Miller A, Hammen C, Weihs KL, et al. Chronic Stress in Vocational and Intimate Partner Domains as Predictors of Depressive Symptoms After Breast Cancer Diagnosis. Annals Behavioral Medicine. 2019;53(4):33344. https://doi.org/10.1093/abm/kay045
10. Bouchard LC, Fisher HM, Carver CS, Kim Y, Antoni MH. Social comparisons predict health-related quality of life and depressive symptoms across the first year of breast cancer treatment. Psycho? Oncology. 2019;28:3⇵. https://doi.org/10.1002/pon.4954
11. Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings:a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12:16074. https://doi:10.1016/S1470-2045(11)70002-X
12. Fann JR, Thomas RA, Katon WJ, Cowley D, Pepping M, Mcgregor BA, et al. Major depression after breast cancer:a review of epidemiology and treatment. Gen Hosp Psychia. 2008;30(2);11226. https://doi:10.1016/j.genhosppsych.2007.10.008
13. Zhu L, Ranchor AV, Helgeson VS, van der Lee M, Garssen B, Stewart RE, et al. Benefit finding trajectories in cancer patients receiving psychological care:Predictors and relations to depressive and anxiety symptoms. Br J Health Psychol. 2018;23(2):23852. https://doi.org/10.1111/bjhp.12283
14. Rowland JH. Anxiety and the blues after breast cancer:how common are they?CNS Spectr. 1999;4(10):40-54. https://doi:10.1017/s1092852900012359
15. Boyle CC, Stanton AL, Ganz PA, Crespi CM, Bower JE. Improvements in emotion regulation following mindfulness meditation:Effects on depressive symptoms and perceived stress in younger breast cancer survivors. J Consult Clinical Psychol. 2017;85(4):397-402. https://doi:10.1037/ccp0000186
16. Fervaha G, Izard JP, Tripp DA, Rajan S, Leong DP, Siemens DR. Depression and prostate cancer:A focused review for the clinician. Urol Oncol. 2019;37(4):2828. https://doi:10.1016/j.urolonc.2018.12.020
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 5th Edition. Arlington:American Psychiatric Association;2013.
18. Walker J, Hansen CH, Martin P, Symeonides S, Ramessur R, Murray G, et al. Prevalence, associations, and adequacy of treatment of major depression in patients with cancer:a cross-sectional analysis of routinely collected clinical data. Lancet Psychiatry. 2014;1(5):343-50. https://doi:10.1016/S2215-0366(14)70313-X
19. Guinot JL. La depresión en el paciente oncológico en la fase final de la vida. Cuadernos Monográficos de PsicoBioquímica. 2013;2:5-13. Disponible en http://www.psicobioquimica.org/cancer_depresion_1_01.html
20. Watts S, Prescott P, Mason J, McLeod N, Lewith G. Depression and anxiety in ovarian cancer:a systematic review and meta-analysis of prevalence rates. BMJ Open. 2015;5(11):e007618. https://doi:10.1136/bmjopen-2015-007618
21. Spiegel D, Riba MB. Managing anxiety and depression during treatment. Breast J. 2015;21(1):97-103. https://doi:10.1111/tbj.12355
22. Danhauer SC, Addington EL, Sohl SJ, Chaoul A, Cohen L. Review of yoga therapy during cancer treatment. Support Care Cancer. 2017;25(4):1357-72. https://doi:10.1007/s00520-016-3556-9
23. García-Fabela RO. Prevalencia de depresión en una población de pacientes con cáncer. Gaceta Mex Oncología. 2010;9(3):89-93. Disponible en https://biblat.unam.mx/hevila/Gacetamexicanadeoncologia/2010/vol9/no3/2.pdf
24. Maass SW, Roorda C, Berendsen AJ, Verhaak PF, de Bock GH. The prevalence of long-term symptoms of depression and anxiety after breast cancer treatment:A systematic review. Maturitas. 2015;82(1):100-8. https://doi:10.1016/j.maturitas.2015.04.010
25. Cramer H, Lauche R, Paul A, Langhorst J, Kümmel S, Dobos GJ. Hypnosis in breast cancer care:a systematic review of randomized controlled trials. Integr Cancer Ther. 2015;14(1):5-15. https://doi:10.1177/1534735414550035
26. Eason AD, Parris BA. Clinical applications of self-hypnosis:A systematic review and meta-analysis of randomized controlled trials. Psychology Consciousness:Theory, Research, and Practice. 2019;6(3):262-78. https://psycnet.apa.org/doi/10.1037/cns0000173
27. Edwards L. The Other Side of the Valley:Healing Through Altered States of Consciousness. Alresford, Hampshire, UK:O-Books;2019.
28. Wagland R, Richardson A, Armes J, Hankins M, Lennan E, Griffiths P. Treatment-related problems experiences by cancer patients undergoing chemotherapy:a scoping review. Eur J Cancer Care. 2015;24(5):60517. https://doi:10.1111/ecc.12246
29. Vargay A, KalóZS, Zsigmond O, Józsa E, ThurzóT, Kóber G, et al. Analysis of subjective experiences of breast cancer patients receiving hypnosis, music, or special attention, during chemotherapy treatment:A content analysis. Developments Health Sciences. 2018;1(3):70-7. https://doi:10.1556/2066.2.2018.19
30. Montgomery GH, David D, Kangas M, Green S, Sucala M, Bovbjerg DH, et al. Randomized controlled trial of a cognitive-behavioral therapy plus hypnosis intervention to control fatigue in patients undergoing radiotherapy for breast cancer. J Clin Oncol. 2014;32(6):55763. https://doi:10.1200/JCO.2013.49.3437
31. Segal ZV, Williams M, Teasdale J. Mindfulness-based cognitive therapy for depression. Second Edition. Guilford Publications;2018.
32. Reich RR, Lengacher CA, Alinat CB, Kip KE, Paterson C, Ramesar S, et al. Mindfulness-based stress reduction in post-treatment breast cancer patients:immediate and sustained effects across multiple symptom clusters. J Pain Symptom Manage. 2017;53(1):↓. https://doi:10.1016/j.jpainsymman.2016.08.005
33. Bower JE, Crosswell AD, Stanton AL, Crespi CM, Winston D, Arevalo J, et al. Mindfulness meditation for younger breast cancer survivors:a randomized controlled trial. Cancer. 2015;121(8):123140. https://doi:10.1002/cncr.29194
34. Kim YH, Kim HJ, Ahn SD, Seo YJ, Kim SH. Effects of meditation on anxiety, depression, fatigue, and quality of life of women undergoing radiation therapy for breast cancer. Complement Therapies Med. 2013;21(4):3797. https://doi:10.1016/j.ctim.2013.06.005
35. Tang Y, Fu F, Gao H, Shen L, Chi I, Bai Z. Art therapy for anxiety, depression, and fatigue in females with breast cancer:A systematic review. J Psychosoc Oncol. 2018;37(1):7995. https://doi.org/10.1080/07347332.2018.1506855
36. Lengacher CA, Reich RR, Paterson CL, Ramesar S, Park JY, Alinat C, et al. Examination of broad symptom improvement resulting from mindfulness-based stress reduction in breast cancer survivors:a randomized controlled trial. J Clin Oncol. 2016;34(24):282734. https://doi:10.1200/JCO.2015.65.7874
37. Cobeanu O, David D. Alleviation of Side Effects and Distress in Breast Cancer Patients by Cognitive-Behavioral Interventions:A Systematic Review and Meta-analysis. J Clinical Psych Med Settings. 2018;25(4):33555.https://doi:10.1007/s10880-017-9526-7
38. CastrezanaCampos MR. Geografía del cáncer de mama en México. Investigaciones Geográficas.2017;93. http://dx.doi.org/10.14350/rig.56879
39. Leal YA, Reynoso-Noverón N, Aguilar-Castillejos LF, Meneses-García A, Mohar A, Piñeros M. Implementation of the population-based cancer registry in the city of Merida, Mexico:process and early results. Salud Publica Mex. 2020;62:96-104. https://doi.org/10.21149/10501
40. Ornelas-Mejorada RE, Tufiño-Tufiño MA, Sánchez-Sosa JJ. Ansiedad y Depresión en Mujeres con Cáncer de Mama en Radioterapia:Prevalencia y Factores Asociados. Acta Investigación Psicológica. 2011;1(3):40114. Disponible en http://www.scielo.org.mx/pdf/aip/v1n3/v1n3a3.pdf
41. Pérez-Fortis A, Schroevers MJ, Fleer J, Alanís-López P, Veloz-Martínez MG, Ornelas-Mejorada RE, et al. Psychological burden at the time of diagnosis among Mexican breast cancer patients. Psycho-Oncology 2017;26(1):133-6. http://doi:10.1002/pon.4098
42. Sánchez-Huerta MS, Figueroa-López CG, Cacho-Díaz B, Robles-García R. Relación entre síntomas autonómicos con niveles de ansiedad y depresión en mujeres con cáncer de mama. En-Claves Pensamiento. 2016;10(19):146-62.
43. Morales-Chávez M, Robles-García R, Jiménez-Pérez M, Morales- Romero J. Las mujeres mexicanas con cáncer de mama presentan una alta prevalencia de depresión y ansiedad. Salud Publica Mex. 2007;49(4):2478. http://doi:10.1590/s0036-36342007000400003
44. Almanza-Muñoz JJ, RosarioJuárez I, SilvaOrtiz J, HuertaSánchez R. Distrés psicosocial y trastornos mentales en una muestra de pacientes mexicanos con cáncer. Rev Sanid Milit Mex. 2009;63(4):14855.
45. Aguilar-Cordero MJ, Mur-Villar N, Neri-Sanchez M, Pimentel-Ramírez ML, García-Rillo A, Gómez-Valverde E. Breast cancer and body image as a prognostic factor of depression:a case study in Mexico City. Nutr Hosp. 2014;31(1):371-9. http//doi:10.3305/nh.2015.31.1.7863
46. Téllez A, Rodríguez-Padilla C, Martínez-Rodríguez JL, Juárez-García DM, Sánchez-Armas O, Sánchez T, et al. Psychological Effects of Group Hypnotherapy on Breast Cancer Patients During Chemotherapy. Am J Clin Hypn. 2017;60(1):68-84. http//doi:10.1080/00029157.2016.1210497
47. Gerson-Cwilich R, Serrano-Olvera A, Villalobos-Prieto A. Complementary and alternative medicine (CAM) in Mexican patients with cancer. Clin Transl Oncol. 2006;8(3):2007. http//doi 10.1007/s12094-006-0011-2
##plugins.themes.themeEleven.article.sidebar##
Publicado
15 octubre 2021
Número
Sección
Artículo de revisión
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Los autores conservan sus derechos de autor y otorgan a la Revista Médica del IMSS el derecho de primera publicación. Los artículos se distribuyen bajo una Licencia Creative Commons Atribución-NoComercial-SinDerivar 4.0 Internacional, que permite su difusión siempre que se reconozca al autor y la fuente original.
Biografía del autor/a
Damaris Estrella-Castillo, <p>Facultad de Medicina, Universidad Autónoma de Yucatán</p>
Facultad de Medicina- Cuerpo Académico de Salud Pública, Universidad Autónoma de Yucatán
Roberto Carlos Pech-Argüelles, <p>INSTITUTO MEXICANO DEL SEGURO SOCIAL. Mérida.</p>
Coordinación Médica CICyRC de la UMAE-Mérida del IMSS.
Ingrid Olais-Arjona, <p>Facultad de Medicina, Universidad Autónoma de Yucatán</p>
Facultad de Medicina- Cuerpo Académico de Salud Pública, Universidad Autónoma de Yucatán
Hector Rubio-Zapata, <p>Facultad de Medicina, Universidad Autónoma de Yucatán</p>
Facultad de Medicina- Cuerpo Académico de Salud Pública, Universidad Autónoma de Yucatán
Yelda Aurora Leal-Herrera, <p>INSTITUTO MEXICANO DEL SEGURO SOCIAL. Mérida.</p>
Titular del Centro Institucional de Capacitación y Registro de Cáncer de la Unidad Médica de Alta Especialidad de Mérida
Cómo citar
1.
Estrella-Castillo D, Pech-Argüelles RC, Olais-Arjona I, Rubio-Zapata H, Leal-Herrera YA. Evidencia científica de la relación entre depresión y cáncer de mama: revisión sistemática. Rev Med Inst Mex Seguro Soc [Internet]. 2021 Oct. 15 [cited 2025 Aug. 3];58(Supl 1):S91-96. Available from: https://revistamedica.imss.gob.mx/index.php/revista_medica/article/view/3322